Taotao Ling

Dr. Taotao Ling


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Molecules
Verified
Journal Article
Open access
PDF file
BBBenedict Barras
Benedict Barras
TLTaotao Ling
Taotao Ling
FRFatima Rivas
Fatima Rivas
Monoterpenes and meroterpenes are two large classes of isoprene-based molecules produced by terrestrial plants and unicellular organisms as diverse secondary metabolites. The global rising incidence of cancer has led to a renewed interest in natural products. These monoterpenes and meroterpenes represent a novel source of molecular scaffolds that can serve as medicinal chemistry platforms for the development of potential preclinical leads. Furthermore, some of these natural products are either abundant, or their synthetic strategies are scalable as it will be indicated here, facilitating their derivatization to expand their scope in drug discovery. This review is a collection of representative updates (from 2016–2023) in biologically active monoterpene and meroterpenoid natural products and focuses on the recent findings of the pharmacological potential of these bioactive compounds as well as the newly developed synthetic strategies employed to access them. Particular emphasis will be placed on the anticancer and antioxidant potential of these compounds in order to raise knowledge for further investigations into the development of potential anti-cancer therapeutics. The mounting experimental evidence from various research groups across the globe regarding the use of these natural products at pre-clinical levels, renders them a fast-track research area worth of attention.

Verified
Journal Article
Open access
PDF file
AAAliyah Lyam Bocachica Adorno
Aliyah Lyam Bocachica Adorno
AAAdriana Y. Aponte-Ramos
Adriana Y. Aponte-Ramos
PRPaola Sofía Rivera-Fuentes
Paola Sofía Rivera-Fuentes
NENatalia Paola Espinosa
Natalia Paola Espinosa
LUZ V. ARROYO-CRUZLUZ V. ARROYO-CRUZ
LUZ V. ARROYO-CRUZ
Michelle M. Martinez-MontemayorMichelle M. Martinez-Montemayor
Michelle M. Martinez-Montemayor
Ergosterol peroxide (EP) triggers apoptosis pathways by inducing reactive oxygen species (ROS) in TNBC cell lines. Excess ROS production is associated with major damage to mitochondria. We hypothesized that EP may act through ROS-induced mitochondrial dysfunction. Therefore, we performed a series of assays that assessed mitochondrial membrane potential (MMP), cellular respiration, and glycolysis in TNBC models. Cardiomyocytes derived from human-induced pluripotent stem cells were chosen as a non-cancerous model because of their high mitochondrial content. Two in vivo TNBC models were used to quantify the effect of EP on tumor volume and metastases. EP reduced MMP and disrupted mitochondrial functions exclusively in TNBC cells. In vivo EP was effective in reducing tumor volume without affecting liver function. There was also a significant decrease in metastasis to the lung, liver, and cancer stem cells following treatment. These results suggest EP is a promising therapy for TNBC.

1 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LUZ V. ARROYO-CRUZLUZ V. ARROYO-CRUZ
LUZ V. ARROYO-CRUZ
SSSebastián Sagardía-González
Sebastián Sagardía-González
KMKurt Miller
Kurt Miller
TLTaotao Ling
Taotao Ling
FRFatima Rivas
Fatima Rivas
Michelle M. Martinez-MontemayorMichelle M. Martinez-Montemayor
Michelle M. Martinez-Montemayor
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor type 2 expression. It is known for its high malignancy, invasiveness, and propensity for metastasis, resulting in a poor prognosis due to the absence of beneficial therapeutic targets. Natural products derived from mushrooms have gained significant attention in neoplastic therapy due to their potential medicinal properties. The therapeutic potential of Ganoderma lucidum in breast cancer has been highlighted by our group, suggesting its use as an adjuvant treatment. The present study aims to assess the potential antineoplastic capacity of two Caribbean native Ganoderma species found in Puerto Rico, Ganoderma multiplicatum (G. multiplicatum) and Ganoderma martinicense (G. martinicense). Antiproliferative studies were conducted via cell viability assays after cultivation, harvesting, and fractionation of both species. The obtained results indicate that most of the fractions show some cytotoxicity against all cell lines, but 33% of the fractions (F1, F2, F7, F12) display selectivity towards cancer cell models. We demonstrate for the first time that native Ganoderma species can generate metabolites with anti-TNBC properties. Future avenues will focus on structure elucidation of the most active fractions of these Ganoderma extracts.